German pharmaceutical company Stada Arzneimittel is intended to be fully acquired by either Cinven Partners and Advent International Corporation, which have both submitted bids.
Both companies that bid for the acquisition are based in the US.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
US-based biopharmaceutical company NexImmune has been fully acquired by a consortium of private investors.
The acquisition will help NexImmune expand its portfolio in immuno-oncology and other immune-mediated disease areas.
The consortium, led by Celgene and CEOs of Medtronic, also includes other private investors.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
